2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Metastatic Leiomyosarcoma: new trials by email Literature Review of Metastatic Leiomyosarcoma trials Research Report on Metastatic Leiomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma Mocetinostat, Gemcitabine - Metastatic Leiomyosarcoma | Phase 2 | Completed | Sarcoma Alliance for Research through Collaboration | 20 | 2015-11-12 | 2019-01-29 |
| Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 20 | 2015-05-19 | 2025-02-25 |
Leiomyosarcoma (2)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Muscle Tissue (2) · Sarcoma (2)
CTLA-4 Antigen (1) · Gemcitabine (1) · Ipilimumab (1) · Nivolumab (1) · mocetinostat (1)
National Cancer Institute (NCI) (1) · Sarcoma Alliance for Research through Collaboration (1)
United States (2)
Edwin Choy, MD, PhD (1) · Shreyas Patel, MD (1) · Suzanne George (1)
UM1CA186709 (1)